Search results

Australia’s new Mo-99 manufacturing facility reaches practical completion

A new radiocarbon dating facility opened at the University of New South Wales (UNSW) will complement the extensive radiocarbon facilities at ANSTO’s world-leading Centre for Accelerator Science

The Australian Nuclear Science and Technology Organisation (ANSTO) has joined a team, lead by the US Department of Energy’s Pacific Northwest National Laboratory (PNNL), to install a high resolution monitoring system at ANSTO’s medical isotope production facility in Lucas Heights, Australia.

Event held to mark anniversary of SPRing-8 in Japan.

Over the past 70 years ANSTO has been building Australia’s nuclear expertise and despite being small in scale, today we are complex and sophisticated nuclear nation.

ANSTO radiocarbon facilities and scientists are featured in a new IMAX documentary film released in the United States.

An accomplished international photographer has capture dazzling new images of one component of the main ring at our Australian Synchrotron and provided an inside view of the electron’s path when it is used.

ANSTO today welcomed a significant Federal Government funding allocation to further safeguard the production of life-saving nuclear medicines in Australia.

ANSTO will make an application to the independent nuclear regulator, ARPANSA, to vary its license for its Interim Waste Store. The original operating license was approved in 2015, enabling the facility to hold what is called a TN-81 cask of intermediate-level radioactive waste that was safely repatriated from France in 2015.

Consultant appointed to consider a variety of financial, manufacture and import options.

On the international stage amongst the leading nuclear nations of the world, Australians hold its own. This status has been earned by ANSTO’s seventy-year history of safe nuclear operations, the application of nuclear science and technology to benefit society and nuclear stewardship role in Australia.

Neutron Capture Enhanced Particle Therapy developed at ANSTO.

Accelerator Mass Spectrometry (AMS) is an ultra-sensitive analytical technique based on the use of an ion accelerator as a powerful mass spectrometer.

Seven of Australia’s top nuclear medicine professionals have been briefed on ANSTO’s plans to manage radioactive waste, as well as to support nuclear medicine innovation in Australia.